India Is No Longer a Future Option. It Is a Current Decision
The negotiations between Germany and India on a Free Trade Agreement are entering their final stage. This is not a symbolic milestone. It signals a clear strategic shift in German trade policy.
Chancellor Friedrich Merz’s recent visit to India makes this shift tangible. Germany is actively seeking reliable partners beyond the United States. With U.S. tariff policies creating long-term uncertainty, diversification is no longer optional. It is essential.
India stands out not just as a low-cost manufacturing base. It is a growth market with scale, demand, and momentum of its own. The opportunity lies in the size of its consumer base, the speed of digital adoption, and the readiness of its population to embrace new products.
Big Tech Is Not Testing India. It Is Committing to It
Meta, Google, and Amazon are investing billions in India’s digital ecosystem. These investments span infrastructure, artificial intelligence, cloud services, and logistics networks. Amazon alone has announced plans to invest more than US$35 billion by 2030, targeting AI, logistics, exports, and operational capacity to expand its influence across sectors.
This is not experimental capital. It is a long-term bet on India’s role as a digital-first consumer economy. When companies of this scale commit at this depth, they are not reacting to short-term growth. They are shaping the environment in which future commerce will operate. For traditional industries, including OTC and pharma, this is a signal worth paying attention to.
Why India Matters Now
India’s growth story is no longer a projection. It is visible in everyday consumer behavior.
The country’s e-commerce industry, valued at Rs. 10,82,875 crore or roughly US$125 billion in 2024, is expected to grow to Rs. 29,88,735 crore or US$345 billion by 2030. Growth in the near term remains strong, with annual increases of 25 to 30 percent expected.
Online shopping has become routine across income groups and regions. Since the pandemic, smartphones have become the primary access point. Consumers across ages and social classes discovered the convenience of online shopping and stayed with it. Digital payments are now mainstream. More than 60 percent of the population uses them regularly. This reduces friction and increases confidence when trying new brands.
What stands out most is openness. Indian consumers are willing to try new products when value and credibility are clear. This is particularly true in health, wellness, and personal care categories, which sit very close to OTC.
Brand loyalty exists, but it is not automatic. It is earned through consistent performance, transparency, and reliable availability. This creates a market where new entrants can scale quickly, provided they understand local consumer behavior and move early.
From my personal perspective, I had the opportunity to engage with the two largest and most influential players in India’s online pharmacy market – Amazon and Tata. We had very insightful conversations with multiple teams, ranging from India onboarding to key account management and lead advertising. One thing quickly became clear – in India, no meaningful conversation happens without tea.
OTC Products Are Well Positioned for This Market
OTC and consumer health products sit at the center of India’s shift toward digital-first consumption. India is notably future-oriented when it comes to digital health and telemedicine, with rapid adoption across large parts of the population.
Consumer behavior has evolved quickly. Health awareness is rising at a remarkable pace. People are paying closer attention to prevention, daily wellbeing, nutrition, and self-care. Rather than focusing only on solutions for acute illness, consumers are actively looking for products that integrate naturally into everyday life.
Prescription medicines in India are still predominantly distributed through traditional retail pharmacies. OTC products, however, are growing online faster than almost any other consumer category.
The underlying pattern may look familiar from Western markets, but the dynamics are very different. Adoption happens faster. Willingness to experiment is higher. And digital discovery plays a significantly larger role in shaping purchasing decisions.
Key Segments and Consumer Trends
Fast-growing digital categories in India include wellness and nutraceuticals, vitamins and supplements, and beauty and personal care products that increasingly combine health and lifestyle benefits.
Online channels lower the barrier to trial. Consumers can research ingredients, compare products, read reviews, and reorder with ease. This supports repeat purchase and helps build long-term brand relationships.
For German OTC manufacturers, this represents a strategic entry point. It allows brands to engage directly with consumers and build trust before entering more complex regulatory or prescription-driven segments.
There is also a deeper dynamic at play
OTC is not separate from India’s healthcare journey. It is often the first step. As consumers become comfortable ordering health products online, trust increases. Digital engagement deepens. Brand equity can form before a broader regulatory footprint is established.
Logistics, Infrastructure, and the Digital Backbone
India’s digital market is supported by rapidly expanding physical infrastructure.
Flipkart has rolled out micro-fulfillment centers across 19 cities. Amazon continues to expand fulfillment centers and sorting hubs to support faster delivery. The Government e-Marketplace reports strong growth in public procurement, showing that digital commerce in India extends well beyond consumer retail.
These investments are not limited to quick commerce. They support digital health distribution, cold chain development, and cross-border export capabilities.
Amazon projects that India-based exports will grow from US$20 billion to US$80 billion by 2030. This highlights India’s emerging role not only as a consumer market but also as a global distribution hub.
In practical terms, India is building the logistics foundation that makes both fast-moving consumer goods and regulated healthcare products competitive online.
What This Means for German OTC Leaders
For German OTC leaders, India should no longer be treated as an optional expansion market. It requires strategic attention at the highest level.
- First, India demands a dedicated approach. It cannot be managed as a side project or an extension of existing Asia strategies. Scale, complexity, and speed require focus.
- Second, digital must come first. In India, digital discovery often precedes physical retail presence. Brands that delay digital entry risk missing the phase where trust and habits are formed.
- Third, OTC should be viewed as a strategic spearhead. It offers faster market learning, direct consumer access, and brand building opportunities that prescription segments cannot provide at the same speed.
- Fourth, localization matters. This applies to communication, education, pricing, and platform strategy. Success depends on understanding how Indian consumers evaluate health products and what they expect from brands.
- Fifth, partnerships are critical. Platforms, local distributors, regulatory experts, and logistics partners are not optional. They are essential enablers of scale.
Finally, timing matters. Not aggressive speed, but deliberate momentum. Markets like India reward those who enter early enough to shape categories rather than compete on price later.
A Question That Can No Longer Be Avoided
India is moving forward. Digital infrastructure is expanding. Consumer habits are forming. Platforms are consolidating influence. The market is not waiting for European boardrooms to reach consensus.
For German OTC and pharmaceutical companies, the question is no longer whether India is interesting. The real question is whether you want to enter while the market is still forming its preferences, or after those preferences are already locked in.
India from the personal perspective
Another incredibly exciting and multifaceted journey for me. I have been to India several times now, and each visit continues to reshape my perspective on the market.
What consistently impresses me is the level of digitalization. In many areas, India is light years ahead. Even street vendors and beggars primarily use digital payments today. In major metropolitan areas, same-day or even same-hour delivery is already the norm. This is not a future scenario. It is everyday reality.
What also stands out is the momentum of the growing middle class. Hundreds of millions of people with rising incomes, high digital affinity, and strong openness to new brands are driving the market forward. E-commerce, mobile-first behavior, and digital services are deeply embedded in daily life.
Visits to Amazon and Tata once again highlighted the speed and confidence with which this market is developing. Growth is not treated as an ambition. It is the baseline assumption. Processes, infrastructure, and decisions are all designed around that reality.
For OTC manufacturers, as well as companies in cosmetics, natural health, and consumer health, this creates enormous opportunity. India is not just a sales market. It is a learning market, a scaling market, and increasingly an innovation market.
On the ground, we have deliberately built the right infrastructure and a strong network. Our goal is to support companies end to end, from market analysis and entry to imports, registrations, and sales. India is complex, but it is manageable with the right approach.
My most important takeaway after multiple visits is clear. Companies need to actively engage with India. Understand its e-commerce landscape. Protect their brands early. And be willing to act as first movers.
Because while Europe is still debating, India is already moving.

